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Background 
• Pancreatic cancer has surpassed breast cancer as the 3rd  leading 
cause of U.S. cancer deaths, with 41,780 deaths in 20161 
• Projected to be 2nd leading cause of cancer death by 20302 
• Mean direct medical costs of $65,700 per patient (2000-2007)3 
• Five-year survival rate is 7.7%1, due to often advanced stage at 
diagnosis, lack of effective treatment options 
 
• Five-year survival rate for pancreatic cancer patients 
undergoing resection, the only potentially curative treatment, is 
18-24%4 
• Pancreatic cancer resection is underused in eligible patients5-7 
• Factors associated with underuse of pancreatic cancer 
resection are poorly understood 
 
 
 Objective 
Identify factors associated with resection in a national sample of 
locoregional pancreatic cancer patients 
 
Discussion 
Methods 
Data Source 
Surveillance, Epidemiology and End Results (SEER) dataset8 
• National Cancer Institute cancer statistics program 
• Cancer demographics, incidence, treatment and survival data 
• Combines data from 20 regional and state registries; covers 30% of 
U.S. population 
• 8,689,771 total cancer cases from 1973-2014 
 
Study Population  
Inclusion criteria 
• 2004-2012 SEER patients, age 15-89, with primary diagnosis of 
locoregional (Stage I or II) pancreatic cancer in the pancreas head, 
body, or tail 
• Staging based on American Joint Committee on Cancer (AJCC6)9 
criteria instituted in 2004 
Exclusion criteria:  
• Pancreatic cancer diagnosis via death certificate or autopsy   
• Incomplete survival data 
• Incomplete surgical data 
 
Statistical Analyses  
• Primary outcome: receipt of pancreatic cancer resection  
• Descriptive statistics to characterize sample 
• Chi-square tests to identify associations between demographic 
variables and pancreatic cancer resection  
• Multivariate logistic regression to build final model of associations 
between covariates and pancreatic cancer resection 
• Model fit assessed using  Hosmer-Lemeshow test 
• All analyses performed using Statistical Analysis System (SAS) 
Studio software10  
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Results 
• Nearly half of patients with locoregional pancreatic cancer do not 
receive surgery; the reason why is often unclear 
• Factors associated with lower resection rates are non-white 
race/ethnicity, older age, male sex and being unmarried  
• Understanding and addressing these disparities could increase 
pancreatic cancer resection rates and improve survival 
 Limitations 
• Observational data limits ability to make causal inferences 
• Some variables associated with resection (comorbidities, insurance, 
socioeconomic status) 4 are not available in SEER 
• No details on resection decision-making process 
Recommendations for Future Research 
• Perform sensitivity analysis and instrumental variable analysis  
• Explore SEER-Medicare linked data 
• Analyze regional care patterns and the impact of high-volume 
pancreatic surgery hospitals on resection rates  
• Conduct interviews with physicians, patients and their caregivers on 
resection decision-making process 
   Table 1.Demographics of final sample  
Characteristic Resection N(%) No resection 
N(%) 
p-value 
Total (N=16,676) 8524(51.1) 8152(48.9) 
Age Category <.001 
  <65 4088(48.0) 2325(28.5) 
  65-74 2647(31.1) 2120(26.0) 
  ≥75 1780(21.0) 3707(45.5) 
Sex <.001 
  Male 4290(52.7) 3857(47.3) 
  Female 4234(49.6) 4295(50.4) 
Race/Ethnicity <.001 
  White/Non Hispanic 6187(52.2) 5665(47.8) 
  Non-Hispanic Black 879(45.9) 1034(54.1) 
  Hispanic  804(48.9) 840(51.1) 
  Other Race/Ethnicity 654(51.6) 613(48.4) 
Marital Status <.001 
  Married 5328(56.2) 44159(43.8) 
  Not married 3196(44.5) 3993(55.5) 
Registry <.001 
Diagnosis Year  .313 
  2004-2006 2390(49.9) 2398(50.1) 
  2007-2009 2934(52.1) 2699(47.9) 
  2010-2012 3200(51.2) 3055(48.8) 
AJCC Stage <.001 
  Stage I 1537(39.7) 2332(60.3) 
  Stage II 6987(54.6) 5820(45.4) 
Tumor Location <.001 
  Head 6930(49.8) 6994(50.2) 
  Body 555(41.0) 799(59.0) 
  Tail 1039(74.3) 359(25.7) 
Final Sample: 16,676 
Exclusion of unreliable surgical data  
16,676 
Exclusion of unreliable diagnostic data/diagnosis via death certificate or autopsy 
16,676 
Pancreatic cancer is primary tumor  
17,781 
Locoregional pancreatic cancer  
22,294 
Age 15-89 
62,248 
Pancreatic cancer diagnosed 2004-2012 
64,540 
Malignant pancreatic cancer 
131,862 
Pancreatic cancer in head, body, or tail 
132,247 
All SEER pancreatic cancer cases 
197,864 
Table 2. Odds of Undergoing Resection 
Variable Univariate Analysis  
Odds Ratio (CI) 
Multivariate Analysis* 
Odds Ratio (CI) 
Age Category 
  >65 Reference Reference 
  65-74 .71[.66-.77] .70[.65-.76] 
  ≥ 75 .28[.26-.30] .28[.25-.30] 
Sex 
  Female Reference Reference 
  Male .89[.83-.94] .91[.85-.98] 
Race/Ethnicity 
  White/Non-Hispanic Reference Reference 
  Non-Hispanic Black .78[.71-.86] .69[.62-.77] 
  Hispanic .88[.79-.97] .80[.71-.89] 
  Other race/ethnicity .98[.87-1.10] .86[.75-.98] 
Marital Status 
  Married Reference Reference  
  Not married .63[.59-.67] .71[.66-.76] 
Results(contd.) 
79.40% 
10.14% 
4.23% 3.65% 2.58% 
Surgery not recommended
Contraindicated due to other
condition
Patient or patient's guardian
refused
Unknown reason
Other
Figure 2. Reason Given for No Surgery (N=8152) 
Final sample: 16,676  locoregional pancreatic cancer patients (Figure 1, Table 1), 
of whom 8152 (48.9%) did not receive surgery (Figure 2)  
 
Variables associated with not receiving surgery (controlling for registry, stage, 
and tumor location)(Table 2): 
1. Age: 65-74 30% less likely; 75 or older 72% less likely to undergo resection 
2. Sex: Men 9% less likely to undergo resection 
3. Race/ethnicity: Non-Hispanic black individuals 31% less likely, Hispanic 20% 
less likely, other non-white race/ethnicity 14% less likely to undergo resection 
4. Marital status: Unmarried individuals 29% less likely to undergo resection 
* Controlling for registry, stage, and tumor location 
Figure 1. Stepwise Cohort  Ascertainment     
